Építés alatt – nem éles oldal
Belépés
Toborzás még nem indult4. fázis

Normal Saline Versus Ringer's Lactate for Initial Fluid Resuscitation in Sepsis

A legfontosabb adatok

Ki végzi
Egemen Yildiz
Hol
Törökország1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toborzás még nem indult
Fázis
4. fázis
Résztvevők
88 fő, tervezett
Kezdés
2025. nov.
Várható befejezés
2026. nov.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Ringer's Lactate
  • Normal Saline (0.9% Sodium Chloride)
A regiszteradat frissítve
2025. november 21.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 23 feltétel megnézéseKevesebb

Ki vehet részt

  • Adult male or female patients (≥18 years of age) presenting to the emergency department
  • Diagnosed or suspected sepsis secondary to an infectious cause
  • Provision of written informed consent by the patient, or if the patient is unable to consent, by a first-degree relative or legally authorized representative

Ki nem vehet részt

  • Patients who are receiving cardiopulmonary resuscitation (CPR) or who require endotracheal intubation at the time of presentation
  • Cases in which the treating physician anticipates that fluid therapy might be delayed due to study participation
  • Patients with severe volume depletion unrelated to sepsis (e.g., diabetic ketoacidosis, burns, or active gastrointestinal bleeding)
  • Patients with hypotension that is not related to sepsis (e.g., active hemorrhage or intracranial bleeding)
  • Patients with clinical signs of pulmonary edema or congestive heart failure
  • Cases in which the treating physician determines that one isotonic crystalloid (Ringer's lactate or 0.9% NaCl) is clearly superior to the other due to clinical condition or comorbidities
  • Severe renal failure with oliguria or anuria
  • Decompensated heart failure
  • Conditions associated with impaired lactate metabolism, such as lactic acidosis, severe liver failure, and cirrhosis with ascites
  • Patients with severe hyperkalemia (serum potassium level of at least 6.5 mmol/L with ECG changes)
  • Known hypersensitivity to sodium lactate
  • Age under 18 years old
  • Pregnant women
  • Informed consent was not obtained from the patient or their first-degree relative/legal guardian
  • Patients requiring immediate hospital or ICU admission before completion of initial emergency department resuscitation
  • Patients with sepsis sources requiring urgent invasive intervention known to directly affect mortality (e.g., an undrainable abscess or osteomyelitis); Additional exclusion criteria based on the contraindications listed in the Ringer's lactate product information:,
  • Extracellular hyperhydration or hypervolemia
  • Hypercalcemia
  • Metabolic alkalosis or severe metabolic acidosis
  • Current use of digitalis preparations (e.g., digoxin)

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

This clinical trial aims to determine if the type of intravenous fluid used for initial resuscitation affects the short-term outcomes of adult patients with sepsis who are treated in the emergency department.

A teljes eredeti leírásKevesebb

The main questions it aims to answer are:

Does using Ringer's lactate instead of 0.9% sodium chloride (normal saline) reduce 24-hour mortality in patients with sepsis?

Does the type of fluid influence other short-term outcomes, such as the need for vasopressors, mechanical ventilation, hemodialysis, and length of hospital stay?

Researchers will compare two groups of participants:

* The Ringer's lactate group (intervention group) * The 0.9% sodium chloride group (control group).

Participants will:

* Receive either Ringer's lactate or normal saline for initial fluid resuscitation as part of standard sepsis care. * They will be observed for 24 hours to assess survival and other early outcomes.

A vizsgálat 2 csoportja

  • Ringer's Lactate GroupA vizsgált kezelés

    Eligible participants in this group will receive Ringer's lactate solution as the initial intravenous fluid for resuscitating sepsis. This will be administered through a peripheral intravenous line at a rate of 1000 ml over 30-60 minutes, as determined by the attending physician and the patient's clinical condition. All other treatments will follow standard sepsis care protocols.

    Kezelés: Ringer's Lactate

  • Normal Saline GroupMár használt kezelés, összehasonlításként

    Eligible participants in this arm will receive 0.9% sodium chloride (normal saline) as the initial intravenous fluid for resuscitation in sepsis. This will be administered through a peripheral intravenous line at a rate of 1000 ml over 30-60 minutes, as determined by the attending physician and the patient's clinical condition. All other treatments will follow standard sepsis care protocols.

    Kezelés: Normal Saline (0.9% Sodium Chloride)

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
A Prospective, Single-Center, Randomized Controlled Trial Comparing Normal Saline and Ringer's Lactate for Initial Fluid Resuscitation in Adult Patients With Sepsis in the Emergency Department
A regiszteradat frissítve
2025. november 21.